J B Chemicals scales record high after strong Q1 outcome

Image
Capital Market
Last Updated : Aug 27 2016 | 12:01 AM IST

J B Chemicals & Pharmaceuticals jumped 11.7% to Rs 348.45 at 14:10 IST on BSE after net profit rose 25.79% to Rs 49.85 crore on 7.75% rise in net sales to Rs 300.79 crore in Q1 June 2016 over Q1 June 2015.

The result was announced during market hours today, 26 August 2016.

Meanwhile, the S&P BSE Sensex was down 109.81 points, or 0.39%, to 27,726.10

On BSE, so far 5.61 lakh shares were traded in the counter as against average daily volume of 22,244 shares in the past one quarter. The stock hit a high of Rs 353.75 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 311 so far during the day. The stock had hit a 52-week low of Rs 228.30 on 12 February 2016. The stock had outperformed the market over the past 30 days till 25 August 2016, rising 14.14% compared with Sensex's 0.67% fall. The scrip had also outperformed the market in past one quarter, advancing 22.02% as against Sensex's 4.44% rise.

The small-cap company has an equity capital of Rs 16.96 crore. Face value per share is Rs 2.

J B Chemicals & Pharmaceuticals, one of India's leading pharmaceutical companies, manufactures & markets a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (API)'s.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 26 2016 | 2:14 PM IST

Next Story